| Nephrology | Lifetime | 17 | IN 1 | 99.85 |
| Transplantation | Lifetime | 151 | IN 3 | 95.42 |
| Emergency Medicine | Lifetime | 573 | IN 4 | 94.52 |
| Critical Care and Intensive Care Medicine | Lifetime | 398 | IN 1 | 91.03 |
| Hepatology | Lifetime | 830 | IN 16 | 82.97 |
| Nephrology | 2021-2025 | 23 | IN 2 | 99.51 |
| Surgery | 2021-2025 | 810 | IN 12 | 92.84 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 982 | IN 7 | 78.34 |
| Infectious Diseases | 2021-2025 | 903 | IN 19 | 75.13 |
| Acute Kidney Injury Research | Lifetime | 8 | IN 1 | 99.85 |
| Chronic Kidney Disease and Diabetes | Lifetime | 21 | IN 1 | 99.79 |
| Dialysis and Renal Disease Management | Lifetime | 79 | IN 2 | 99.50 |
| Sepsis Diagnosis and Treatment | Lifetime | 93 | IN 2 | 99.50 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 124 | IN 2 | 99.26 |
| Renal and Vascular Pathologies | Lifetime | 111 | IN 3 | 99.07 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 392 | IN 3 | 99.10 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 54 | IN 1 | 99.12 |
| Organ Donation and Transplantation | Lifetime | 113 | IN 3 | 98.92 |
| Organ Transplantation Techniques and Outcomes | Lifetime | 317 | IN 6 | 98.93 |
| Cardiac Arrest and Resuscitation | Lifetime | 526 | IN 2 | 98.58 |
| Muscle and Compartmental Disorders | Lifetime | 103 | IN 1 | 97.81 |
| Heart Failure Treatment and Management | Lifetime | 810 | IN 2 | 97.25 |
| Hemodynamic Monitoring and Therapy | Lifetime | 631 | IN 3 | 96.71 |
| COVID-19 and healthcare impacts | Lifetime | 754 | IN 14 | 92.97 |
| Renal function and acid-base balance | Lifetime | 916 | IN 5 | 92.86 |
| Potassium and Related Disorders | Lifetime | 613 | IN 2 | 89.71 |
| Nephrotoxicity and Medicinal Plants | Lifetime | 219 | IN 9 | 86.75 |
| Acute Kidney Injury Research | 2021-2025 | 7 | IN 1 | 99.44 |
| Muscle and Compartmental Disorders | 2021-2025 | 4 | IN 1 | 98.59 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 26 | IN 2 | 99.31 |
| Dialysis and Renal Disease Management | 2021-2025 | 100 | IN 3 | 97.82 |
| COVID-19 Clinical Research Studies | 2021-2025 | 924 | IN 21 | 96.28 |
| COVID-19 and healthcare impacts | 2021-2025 | 373 | IN 8 | 94.01 |
| Renal and Vascular Pathologies | 2021-2025 | 190 | IN 7 | 91.68 |
| Renal Transplantation Outcomes and Treatments | 2021-2025 | 813 | IN 7 | 88.32 |
| Organ Donation and Transplantation | 2021-2025 | 406 | IN 9 | 87.48 |
| Renal and related cancers | 2021-2025 | 769 | IN 2 | 83.29 |
| Nephrotoxicity and Medicinal Plants | 2021-2025 | 35 | IN 1 | 78.51 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | 2021-2025 | 398 | IN 3 | 81.69 |
| Thermal Regulation in Medicine | 2021-2025 | 925 | IN 14 | 55.36 |
| Neurological Complications and Syndromes | 2021-2025 | 795 | IN 14 | 52.54 |
| Renin-Angiotensin System Studies | 2021-2025 | 975 | IN 15 | 22.62 |
